Jasper Therapeutics, Inc. EFFECT, filed Oct 13, 2022: primary_doc.xml
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 13, 2022 |
| Accession Number: | 0001213900-22-062795 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||